Cite
HARVARD Citation
Gerds, A. et al. (2019). Corrigendum to "Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib" [Leukemia Res. 79 (2019) 38–44]. Leukemia research. pp. 105-. [Online].